Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26
12 Fevereiro 2025 - 6:00PM
Company to Host Conference Call with Live
Q&A, February 26, 2025, at 4:30pm ET / 22:30 CET
IRVINE, CA, and HERSTAL,
BELGIUM – February 12, 2025 (GlobeNewswire) – MDxHealth SA
(NASDAQ: MDXH), a leading precision diagnostics company, today
announced it will release its financial results for the fourth
quarter and full year ended December 31, 2024, after market close
on Wednesday, February 26, 2025.
Title: |
Mdxhealth Presents Fourth Quarter and Full Year 2024 Financial
Results andCorporate Update Conference Call and Webcast |
Speakers: |
Michael K. McGarrity, Chief Executive OfficerRon Kalfus, Chief
Financial Officer |
Date: |
February 26, 2025 |
Time: |
4:30pm ET/ 22:30 CET |
Conference Call Dial-in
Details: |
United States: 1-844-825-9789Belgium: 0800 38 961The Netherlands:
0800 94 94 506United Kingdom: 0808 238 9064 |
Conference ID: |
10196702 |
Webcast: |
https://viavid.webcasts.com/starthere.jsp?ei=1706814&tp_key=e01537d9e2 |
The webcast should be accessed 15 minutes prior to the
conference call start time. A replay of the webcast will be
available following the conclusion of the live call and will be
accessible on the Company’s website.
About Mdxhealth
Mdxhealth is a leading precision diagnostics
company that provides actionable molecular information to
personalize patient diagnosis and treatment. The Company’s tests
are based on proprietary genomic, epigenetic (methylation) and
other molecular technologies and assist physicians with the
diagnosis and prognosis of urologic cancers and other urologic
diseases. The Company’s U.S. headquarters and laboratory operations
are in Irvine, California, with additional laboratory operations in
Plano, Texas. European headquarters are in Herstal, Belgium. For
more information, visit mdxhealth.com and follow us on social media
at: twitter.com/mdxhealth, facebook.com/mdxhealth and
linkedin.com/company/mdxhealth.
MDxHealth info@mdxhealth.com |
|
LifeSci
Advisors (IR & PR)US: +1 949 271
9223ir@mdxhealth.com |
|
MDxHealth (NASDAQ:MDXH)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
MDxHealth (NASDAQ:MDXH)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025